| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.28 | 6e-11 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.28 | 3e-10 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.27 | 7e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.24 | 9e-10 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-09 |